Literature DB >> 11773126

Assessment of clarithromycin-resistant Helicobacter pylori among patients in Shanghai and Guangzhou, China, by primer-mismatch PCR.

Zhi-Jun Pan1, Wan-Wen Su, Guido N J Tytgat, Jacob Dankert, Arie van der Ende.   

Abstract

Of 96 Helicobacter pylori isolates from patients in Shanghai and Guangzhou, China, 5 had the A2143G 23S rRNA mutation as determined by primer-mismatch PCR and were resistant to clarithromycin by the E-test. The remaining isolates were primer-mismatch PCR negative and susceptible to clarithromycin. The conclusion is that the prevalence of clarithromycin-resistant H. pylori isolates among these Chinese patients is 5%.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11773126      PMCID： PMC120094          DOI： 10.1128/JCM.40.1.259-261.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates.

Authors:  T Alarcón; D Domingo; N Prieto; M López-Brea
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Therapy of Helicobacter pylori: current status and issues.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  2000-02       Impact factor: 22.682

3.  Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study.

Authors:  L J van Doorn; Y Glupczynski; J G Kusters; F Mégraud; P Midolo; N Maggi-Solcà; D M Queiroz; N Nouhan; E Stet; W G Quint
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.

Authors:  J Q Huang; S Sridhar; Y Chen; R H Hunt
Journal:  Gastroenterology       Date:  1998-06       Impact factor: 22.682

5.  Attempt to fulfil Koch's postulates for pyloric Campylobacter.

Authors:  B J Marshall; J A Armstrong; D B McGechie; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

Review 6.  Antibiotic resistance problems with Helicobacter pylori.

Authors:  T Alarcón; D Domingo; M López-Brea
Journal:  Int J Antimicrob Agents       Date:  1999-06       Impact factor: 5.283

7.  Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease.

Authors:  A van der Ende; E A Rauws; M Feller; C J Mulder; G N Tytgat; J Dankert
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

8.  High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong.

Authors:  W H Wang; B C Wong; A K Mukhopadhyay; D E Berg; C H Cho; K C Lai; W H Hu; F M Fung; W M Hui; S K Lam
Journal:  Aliment Pharmacol Ther       Date:  2000-07       Impact factor: 8.171

Review 9.  A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates.

Authors:  M H Houben; D van de Beek; E F Hensen; A J de Craen; E A Rauws; G N Tytgat
Journal:  Aliment Pharmacol Ther       Date:  1999-08       Impact factor: 8.171

10.  Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China.

Authors:  Z J Pan; D E Berg; R W van der Hulst; W W Su; A Raudonikiene; S D Xiao; J Dankert; G N Tytgat; A van der Ende
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226
View more
  7 in total

1.  T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh.

Authors:  Rasel Khan; Shamsun Nahar; Jinath Sultana; Mian Mashhud Ahmad; Motiur Rahman
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori.

Authors:  Xiao-Feng Luo; Jian-Hua Jiao; Wen-Yue Zhang; Han-Ming Pu; Bao-Jin Qu; Bing-Ya Yang; Min Hou; Min-Jun Ji
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

3.  Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogotá D.C., Colombia.

Authors:  Alba A Trespalacios; William Otero; Jorge E Caminos; Marcela M Mercado; Jenny Avila; Liliana E Rosero; Azucena Arévalo; Raúl A Poutou-Piñales; David Y Graham
Journal:  J Microbiol       Date:  2013-08-30       Impact factor: 3.422

4.  Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.

Authors:  Wei-Hao Sun; Xi-Long Ou; Da-Zhong Cao; Qian Yu; Ting Yu; Jin-Ming Hu; Feng Zhu; Yun-Liang Sun; Xi-Ling Fu; Han Su
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

5.  Characterization of clarithromycin resistance in isolates of Helicobacter pylori from the UAE.

Authors:  Mubarak S Alfaresi; Abida A Elkoush
Journal:  Indian J Gastroenterol       Date:  2010-07-25

Review 6.  Basis for the management of drug-resistant Helicobacter pylori infection.

Authors:  Francis Mégraud
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history.

Authors:  Zhuoqi Liu; Jing Shen; Lian Zhang; Lin Shen; Qiang Li; Baozhen Zhang; Jing Zhou; Liankun Gu; Guoshuang Feng; Junling Ma; Wei-Cheng You; Dajun Deng
Journal:  BMC Microbiol       Date:  2008-05-28       Impact factor: 3.605
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.